SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-326120
Filing Date
2011-11-30
Accepted
2011-11-30 16:58:55
Documents
4
Period of Report
2011-11-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d262548d8k.htm 8-K 20940
2 ENGLISH TRANSLATION OF PRESS RELEASE OF CELL THERAPEUTICS, INC. d262548dex991.htm EX-99.1 45448
3 GRAPHIC g262548g02y96.jpg GRAPHIC 3090
4 GRAPHIC g262548g59j48.jpg GRAPHIC 4511
  Complete submission text file 0001193125-11-326120.txt   78323
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 111234605
SIC: 2834 Pharmaceutical Preparations